- Investing Ideas
- /
- Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
12
Companies with a Value score of at least 3, ordered by Value score
12 companies
Merck
Market Cap: CL$225.1b
Operates as a healthcare company worldwide.
MRKCL
CL$76,219.00
7D
0%
1Y
-28.2%
Pfizer
Market Cap: US$154.7b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$26.06
7D
0%
1Y
-6.8%
Merck
Market Cap: US$225.1b
Operates as a healthcare company worldwide.
MRK
US$79.14
7D
0%
1Y
-38.6%
Johnson & Johnson
Market Cap: US$448.1b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$166.27
7D
0%
1Y
12.1%
Johnson & Johnson
Market Cap: CL$448.1b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJCL
CL$169,500.00
7D
-2.0%
1Y
10.8%
Gilead Sciences
Market Cap: CL$137.2b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDCL
CL$79,000.00
7D
0%
1Y
8.7%
Biogen
Market Cap: CL$22.6b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIBCL
CL$140,900.00
7D
0%
1Y
-46.0%
Pfizer
Market Cap: CL$154.7b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFECL
CL$23,200.00
7D
0%
1Y
-17.4%
Biogen
Market Cap: US$22.6b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$130.24
7D
0%
1Y
-46.8%
Gilead Sciences
Market Cap: US$137.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$110.43
7D
0%
1Y
38.9%
Amgen
Market Cap: CL$160.7b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGNCL
CL$293,440.00
7D
0%
1Y
-7.1%
Amgen
Market Cap: US$160.7b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$255.16
7D
0%
1Y
0%